Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Seneca Biopharma (SNCA)

Seneca Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNCA
DateTimeSourceHeadlineSymbolCompany
14/06/202323:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
13/06/202323:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
13/06/202323:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
13/06/202323:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
13/06/202323:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
13/06/202323:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
09/06/202314:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
28/04/202311:17Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNCASeneca Biopharma Inc
27/04/202311:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:SNCASeneca Biopharma Inc
21/04/202321:52Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SNCASeneca Biopharma Inc
21/04/202320:41Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SNCASeneca Biopharma Inc
21/04/202320:37Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNCASeneca Biopharma Inc
21/04/202320:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNCASeneca Biopharma Inc
05/04/202323:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
05/04/202323:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
22/03/202321:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNCASeneca Biopharma Inc
13/03/202311:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
15/02/202321:41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNCASeneca Biopharma Inc
13/02/202321:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNCASeneca Biopharma Inc
25/01/202311:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNCASeneca Biopharma Inc
19/01/202311:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SNCASeneca Biopharma Inc
13/01/202322:11Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SNCASeneca Biopharma Inc
04/01/202322:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
04/01/202316:00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNCASeneca Biopharma Inc
16/12/202221:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
16/11/202216:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
14/11/202213:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNCASeneca Biopharma Inc
17/10/202221:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
14/10/202221:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
07/10/202218:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SNCA